Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

2025-522707-26-00
Recruiting
A clinical trial to learn about the effects of IEV407 when given alone or with endocrine therapy in people with advanced breast cancer
Phase 1 · Germany, Spain, France, Italy, Netherlands · 8 sites
Registry update: 21 Oct 2026
2025-522771-28-00
Recruiting
Clinical trial to assess the efficacy and safety of a vaccine for dust mite and Lepidoglyphus destructor allergy.
Phase 3 · Spain · 16 sites
Registry update: 24 Jul 2026
NCT07847710
Recruiting
Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II Trial
Phase 2 · China · 1 site
Registry update: 28 Oct 2026
NCT07825597
Recruiting
Indocyanine Green With Near Infrared Imaging for Intraoperative Visualization of Head and Neck Squamous Cell Carcinoma
Not applicable · United States · 1 site
Registry update: 9 Oct 2026
NCT07843498
Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
Phase 3 · United States · 8 sites
Registry update: 5 Nov 2026
NCT07843472
Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease
Phase 3 · United States · 3 sites
Registry update: 7 Oct 2026
NCT07878923
Recruiting
Early Versus Delayed Start of Ocrevus Zunovo for Relapsing Multiple Sclerosis
Not applicable · United States · 1 site
Registry update: 16 Oct 2026
NCT07484269
Recruiting
PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan
Not applicable · Switzerland · 1 site
Registry update: 30 Oct 2026
NCT07876648
Recruiting
Prospective Trial of [18F]AlF-FAPI-74 for PET Imaging of Fibroblast Activation Protein in Patients With Endometriosis
Phase 2 · Belgium · 1 site
Registry update: 19 Oct 2026
NCT07691047
Recruiting
Reassessment of the Risk of Hemolytic Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With a Regimen Containing Venetoclax
Not applicable · France · 2 sites
Registry update: 13 Oct 2026
NCT07336472
Recruiting
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Phase 1/2 · United States · 6 sites
Registry update: 25 Sept 2026
NCT07800754
Recruiting
A Study in Greece Observing How Patients With Stomach and Esophageal Cancer Are Diagnosed and Treated in Everyday Medical Practice
Not applicable · Greece · 6 sites
Registry update: 8 Oct 2026
NCT07520006
Recruiting
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
Phase 1/2 · United States · 9 sites
Registry update: 3 Nov 2026
NCT07718737
Recruiting
Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
Phase 2/3 · Australia, United States · 7 sites
Registry update: 26 Oct 2026
NCT07795398
Recruiting
DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease
Phase 4 · Denmark · 2 sites
Registry update: 5 Oct 2026
NCT07792681
Recruiting
Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults
Phase 2/3 · China · 83 sites
Registry update: 23 Oct 2026
2026-525328-10-00
Recruiting
A TWO-STAGE, SINGLE-ARM, PHASE II STUDY OF ZONGERTINIB PLUS FULVESTRANT IN PARTICIPANTS WITH HORMONE RECEPTOR-POSITIVE/HER2- NEGATIVE ADVANCED BREAST CANCER HARBORING HER2 MUTATIONS (AGATHA)
Phase 2 · Germany, Spain, Italy · 28 sites
Registry update: 6 Oct 2026
NCT07831824
Recruiting
Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])
Phase 2/3 · United States · 1 site
Registry update: 21 Sept 2026
NCT07873463
Recruiting
Flutemetamol F 18 Injection Formulation Comparison
Phase 2 · United States · 5 sites
Registry update: 5 Nov 2026
NCT07808151
Recruiting
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
Phase 2 · Belgium, Spain, United Kingdom, Italy, Netherlands, United States · 28 sites
Registry update: 27 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.